Endometriosis Withdrawn Phase 1 / 2 Trials for Afatinib (DB08916)

Also known as: Sigmoid endometriosis / Endometriosis, unspecified / Endometriosis (morphologic abnormality) / Endometriosis (disorder) / Endometriosis, site unspecified

IndicationStatusPhase
DBCOND0001340 (Endometriosis)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03481842Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the EndometriosisPrevention